Webinar: CAR-T cell therapies and what it means for patients

June 28, 2022

ALAN and Lymphoma Coalition hosted a free webinar on CAR-T cell therapies and what it means for patients.

In this webinar we spoke about:
– What are CAR-T cell therapies ?
– What does it mean for patient ?
– Experience from patients

About the speakers:

  • Lorna Warwick, CEO of Lymphoma Coalition

Lorna was appointed CEO of the Lymphoma Coalition in December 2018, to provide vision and leadership for the over 80-member strong organisation, having previous been the Coalition’s Director of Strategic Communications and Engagement. Lorna has successfully held senior leadership roles in health charities for more than twenty years and has a diverse background in patient advocacy, mission development, communications, and strategic planning.

Her efforts have been focused on haematological cancers since 2003, at a national (Canada) and global level. Lorna is recognized and respected for strong leadership skills, breadth of knowledge, critical thinking, and patient-focus.

The rich data procured from the biennial Lymphoma Coalition Global Patient Survey on Lymphomas and CLL allows Lorna to truly understand and report on the global patient experience, by subtype, by therapy area, by geographic area, by gender and by age. As a result of her years of experience in evidence-based advocacy and especially in the haematology field, she is frequently asked to present on patient experience, emerging trends and important issues in the lymphoma and CLL landscape.

  • Cerys Thompson, Lymphoma patient

In October 2020, at the age of 29, Cerys was diagnosed with Non-Hodgkin’s Lymphoma – Diffuse Large B-Cell Lymphoma (DLBCL). Cerys went on to have chemotherapy and then CAR-T which she captured in her blog,  A Little Bit of Cancer, to share her experiences with others and demystify the “cancer journey”

  • Sophie Weldon, Acute Leukemia patient

Sophie was diagnosed at 20 years old with ALL whilst she was in the middle of completing my degree. She have been in remission for nearly 3 years now, and started working for Leukaemia Care earlier this year.


Slides presented:

Patient experience